Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal

  • Ambiguity abounds around the terms for pharmaceutical goods under the U.S.-EU trade truce agreed Sunday. Pharma firms are urging clarity over whether their products will be subject to 15% tariffs on EU goods imported to the U.S.